Senzar Asset Management Lowered United Therapeutics Del (UTHR) Position; Pdt Partners Cut By $11.89 Million Its Pool (POOL) Holding

September 14, 2018 - By Ronnie Lemelle

Pool Corporation (NASDAQ:POOL) Logo

Pdt Partners Llc decreased Pool Corporation (POOL) stake by 89.64% reported in 2018Q2 SEC filing. Pdt Partners Llc sold 78,770 shares as Pool Corporation (POOL)’s stock rose 16.32%. The Pdt Partners Llc holds 9,100 shares with $1.38M value, down from 87,870 last quarter. Pool Corporation now has $7.00 billion valuation. The stock increased 0.07% or $0.12 during the last trading session, reaching $173.34. About 49,739 shares traded. Pool Corporation (NASDAQ:POOL) has risen 67.65% since September 14, 2017 and is uptrending. It has outperformed by 52.03% the S&P500. Some Historical POOL News: 20/04/2018 – Pool Corp Closes Below 50-Day Moving Average: Technicals; 21/04/2018 – DJ Pool Corporation, Inst Holders, 1Q 2018 (POOL); 03/05/2018 – Pool Corporation Announces Additional Authorization Under Share Repurchase Program, an Increase in Its Quarterly Cash Dividend and Voting Results for Its 2018 Annual Meeting of Stockholders; 19/04/2018 – Pool Corp 1Q EPS 75c; 24/05/2018 – Pool Corp Presenting at KeyCorp Conference May 31; 31/05/2018 – Pool Corporation to Participate in Citi’s 2018 Small & Mid Cap Conference; 26/04/2018 – Pool Corp at Burkenroad Reports Investment Conference Tomorrow; 15/05/2018 – Capital World Investors Buys New 1% Position in Pool Corp; 13/03/2018 – Pool Corp at Company Marketing Hosted By Stephens Inc. Today; 19/04/2018 – Pool Corp Raises 2018 View To EPS $5.45-EPS $5.70

Senzar Asset Management Llc decreased United Therapeutics Corp Del (UTHR) stake by 94.41% reported in 2018Q2 SEC filing. Senzar Asset Management Llc sold 44,375 shares as United Therapeutics Corp Del (UTHR)’s stock rose 9.57%. The Senzar Asset Management Llc holds 2,625 shares with $297,000 value, down from 47,000 last quarter. United Therapeutics Corp Del now has $5.40B valuation. The stock decreased 0.51% or $0.64 during the last trading session, reaching $123.88. About 59,232 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has risen 0.01% since September 14, 2017 and is uptrending. It has underperformed by 15.61% the S&P500. Some Historical UTHR News: 02/05/2018 – United Therapeutics 1Q Adj EPS $3.76; 30/04/2018 – UNITED THERAPEUTICS TO BUY STEADYMED FOR $4.46/SHR IN CASH; 15/05/2018 – Consonance Capital Management Buys 1.3% of United Therapeutics; 02/05/2018 – UNITED THERAPEUTICS 1Q ADJ. EPS 3.76, EST. $3.56; 30/04/2018 – United Therapeutics to Acquire SteadyMed Ltd. in $216M Deal; 20/04/2018 – DJ United Therapeutics Corporation, Inst Holders, 1Q 2018 (UTHR); 02/05/2018 – UNITED THERAPEUTICS 1Q REV. $389M, EST. $392.4M; 30/04/2018 – UNITED THERAPEUTICS: DEAL VALUED AT $216M; 26/03/2018 Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem’s Strategic Advisory Board; 30/03/2018 – UNITED THERAPEUTICS- NOTIFIED BY FDA CO’S NDA FOR IMPLANTABLE SYSTEM FOR REMODULIN ACCEPTED FOR 6-MONTH REVIEW AS CLASS 2 RESUBMISSION – SEC FILING

More notable recent United Therapeutics Corporation (NASDAQ:UTHR) news were published by: which released: “Why MannKind Stock Is Skyrocketing Today” on September 04, 2018, also with their article: “Mid-Afternoon Market Update: Gold Prices Fall Below $1200; MannKind Shares Spike Higher” published on September 04, 2018, published: “3 Biotech Stocks That Soared This Week: Are They Buys?” on September 08, 2018. More interesting news about United Therapeutics Corporation (NASDAQ:UTHR) were released by: and their article: “Is MannKind Corporation Stock a Buy?” published on September 08, 2018 as well as‘s news article titled: “The Probable Reason Why MannKind Corporation Is Rallying Again” with publication date: September 05, 2018.

Among 3 analysts covering United Therapeutics (NASDAQ:UTHR), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. United Therapeutics had 6 analyst reports since April 3, 2018 according to SRatingsIntel. Credit Suisse maintained United Therapeutics Corporation (NASDAQ:UTHR) on Tuesday, July 10 with “Neutral” rating. Barclays Capital maintained United Therapeutics Corporation (NASDAQ:UTHR) rating on Thursday, May 3. Barclays Capital has “Underweight” rating and $95 target. Credit Suisse maintained the shares of UTHR in report on Thursday, May 3 with “Neutral” rating. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Neutral” rating by Credit Suisse on Tuesday, April 3. The firm has “Outperform” rating by Wedbush given on Thursday, August 2. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Buy” rating by Wedbush on Friday, May 4.

Since March 14, 2018, it had 0 insider purchases, and 13 sales for $20.63 million activity. $121,014 worth of United Therapeutics Corporation (NASDAQ:UTHR) was sold by ROTHBLATT MARTINE A on Thursday, March 22. CAUSEY CHRISTOPHER had sold 810 shares worth $95,580. Giltner Richard also sold $419,198 worth of United Therapeutics Corporation (NASDAQ:UTHR) on Thursday, August 16. 600 shares valued at $67,425 were sold by Olian Judy D. on Tuesday, June 12. On Friday, June 29 DWEK RAYMOND sold $366,353 worth of United Therapeutics Corporation (NASDAQ:UTHR) or 3,240 shares.

Investors sentiment increased to 1.23 in Q2 2018. Its up 0.36, from 0.87 in 2018Q1. It increased, as 21 investors sold UTHR shares while 98 reduced holdings. 35 funds opened positions while 111 raised stakes. 39.78 million shares or 2.89% less from 40.96 million shares in 2018Q1 were reported. Regal Invest Advisors Ltd Liability invested in 14,958 shares. Sei Investments Company holds 0% or 10,854 shares in its portfolio. Regions Corporation owns 180 shares for 0% of their portfolio. 537 are held by Assetmark Incorporated. American International Grp Inc owns 89,807 shares. Nomura Asset Mngmt Limited reported 13,674 shares. South Dakota Inv Council holds 0.12% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 50,100 shares. Amalgamated Bank & Trust holds 8,583 shares or 0.02% of its portfolio. 13 were reported by Earnest Ltd Limited Liability Company. Goldman Sachs Group invested 0.03% in United Therapeutics Corporation (NASDAQ:UTHR). Sumitomo Mitsui Tru Incorporated accumulated 0.02% or 133,523 shares. Utd Services Automobile Association has invested 0.01% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Moreover, Korea Inv Corporation has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 61,256 shares. Hsbc Public Lc has invested 0.01% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Cibc World Markets Inc invested 0.01% in United Therapeutics Corporation (NASDAQ:UTHR).

Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on October, 24. They expect $3.23 EPS, down 48.48% or $3.04 from last year’s $6.27 per share. UTHR’s profit will be $140.72M for 9.59 P/E if the $3.23 EPS becomes a reality. After $3.98 actual EPS reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts -18.84% negative EPS growth.

Investors sentiment decreased to 0.97 in 2018 Q2. Its down 0.10, from 1.07 in 2018Q1. It dropped, as 29 investors sold POOL shares while 97 reduced holdings. 27 funds opened positions while 95 raised stakes. 35.84 million shares or 0.93% less from 36.18 million shares in 2018Q1 were reported. Liberty Mutual Grp Asset Inc holds 8,059 shares or 0.03% of its portfolio. New York-based Canandaigua Natl Bank & Tru has invested 0.09% in Pool Corporation (NASDAQ:POOL). Diligent Invsts Ltd has invested 0.98% in Pool Corporation (NASDAQ:POOL). Rosenblum Silverman Sutton S F Inc Ca holds 1.06% or 20,270 shares in its portfolio. Great West Life Assurance Can reported 36,922 shares. New Mexico Educational Retirement Board stated it has 0.06% in Pool Corporation (NASDAQ:POOL). Advisory Ntwk Lc holds 0% or 45 shares. State Street reported 0.01% stake. Credit Suisse Ag, Switzerland-based fund reported 49,143 shares. Earnest Partners Ltd Com reported 0% stake. Gam Hldgs Ag reported 0.01% stake. Strs Ohio has invested 0% in Pool Corporation (NASDAQ:POOL). Toronto Dominion Bancshares has invested 0% of its portfolio in Pool Corporation (NASDAQ:POOL). Savings Bank Of Hawaii has invested 0.02% in Pool Corporation (NASDAQ:POOL). Bb&T Secs Limited Liability Com owns 7,994 shares.

Among 2 analysts covering Pool (NASDAQ:POOL), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Pool had 2 analyst reports since June 20, 2018 according to SRatingsIntel. The rating was downgraded by Robert W. Baird to “Neutral” on Tuesday, July 3.

Since April 26, 2018, it had 0 insider purchases, and 9 selling transactions for $16.25 million activity. $1.95M worth of Pool Corporation (NASDAQ:POOL) was sold by Joslin Mark W. PEREZ DE LA MESA MANUEL J sold $6.46 million worth of stock or 40,000 shares. 5,766 Pool Corporation (NASDAQ:POOL) shares with value of $939,644 were sold by SLEDD ROBERT C. $1.48M worth of stock was sold by STOKELY JOHN E on Monday, May 21. COOK ARTHUR D sold $322,000 worth of Pool Corporation (NASDAQ:POOL) on Friday, August 24. Shares for $517,821 were sold by HOUSEY HART MELANIE on Thursday, May 10. $824,095 worth of Pool Corporation (NASDAQ:POOL) was sold by NEIL JENNIFER M.

United Therapeutics Corporation (NASDAQ:UTHR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts